Dr. Christopher Anthony Mecoli, MD

Dr. Mecoli practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Mecoli's NPI, 1639469869, was assigned on April 8, 2011. Dr. Mecoli graduated from Rutgers School of Dental Medicine in 2011. Dr. Mecoli holds Maryland license MD920522Z.

Dr. Mecoli's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Mecoli's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Mecoli is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Mecoli to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mecoli practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Mecoli's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Mecoli's licenses on file in 2 states: Maryland and Pennsylvania.

CMS data shows 196 Medicare services from Dr. Mecoli across 3 procedure codes in 2024, for 102 Medicare patients. Medicare paid $13,998 for them.

CMS counts 102 Medicare patients who saw Dr. Mecoli in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mecoli's median patient age at 65, with 67% women.

In 2024, Dr. Mecoli wrote 542 Medicare Part D claims for 72 patients. 61% of them were for generic drugs. CMS names the drug for 444 of them, across 14 drugs with 11 or more claims each, at $2,116,803 in total drug cost. In 2023, CMS named 286 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Mecoli for performance year 2024, reported as part of a group. CMS lists Dr. Mecoli as offering telehealth.

Dmand AI links 62 papers to Dr. Mecoli, published from 2014 to 2025. 2019 was the busiest year, with 9. The most frequent topics are Myositis, Autoantibodies and Dermatomyositis. Dr. Mecoli has published most often in Semin Arthritis Rheum. Dr. Mecoli's most frequent co-authors are Andrew Mammen, MD, Eleni Tiniakou, MD and Laura Kathleen Hummers, MD.

CMS Open Payments shows 29 general payments to Dr. Mecoli from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 84% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $29,556.

Dr. Mecoli graduated from Rutgers School of Dental Medicine in 2011.